Corcillo Antonella, Girardin Sylvie, Andrey Magali, Le Dizès Olivier, Jornayvaz François R
Service d'endocrinologie, diabétologie et métabolisme, CHUV, 1011 Lausanne.
Service d'endocrinologie, diabétologie, hypertension et nutrition, HUG, 1211 Genève 14.
Rev Med Suisse. 2017 May 31;13(565):1140-1144.
Management of type 1 and type 2 diabetes mellitus is getting complex with the apparition of new treatments, but also new technologies. Among these, continuous glucose monitoring systems (CGMS) lead to a better glycemic control and less hypoglycemia in type 1 diabetic patients. Studies are scarce in type 2 diabetes but also seem to show a benefit, particularly in patients using insulin. Nevertheless, type 2 diabetic patients taking advantage of CGMS must be better defined. In any case, a multidisciplinary approach to the use of CGMS and interpretation of data is warranted.
随着新治疗方法以及新技术的出现，1型和2型糖尿病的管理变得愈发复杂。其中，持续葡萄糖监测系统（CGMS）可使1型糖尿病患者实现更好的血糖控制并减少低血糖情况。2型糖尿病方面的研究较少，但似乎也显示出益处，尤其是在使用胰岛素的患者中。然而，必须更明确哪些2型糖尿病患者能从CGMS中获益。无论如何，采用多学科方法来使用CGMS及解读数据是很有必要的。
